Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_assertion type Assertion NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_head.
- NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_assertion description "[EC is known for extensive epigenetic alterations, including overexpression of HDAC and DNMT enzymes, and the frequent epigenetic silencing of DNA repair genes such as MLH1, tumor suppressor genes PTEN, and progesterone receptor, which suggests a potentially high sensitivity of this type of cancer to HDAC inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_provenance.
- NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_assertion evidence source_evidence_literature NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_provenance.
- NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_assertion SIO_000772 23888962 NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_provenance.
- NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_assertion wasDerivedFrom befree-20150227 NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_provenance.
- NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_assertion wasGeneratedBy ECO_0000203 NP654954.RAsSpywTR0NtToymc8WhFQS0VIt3r84zsR1FnzRzp4CK4130_provenance.